Search

Your search keyword '"Hovius, Joppe W."' showing total 430 results

Search Constraints

Start Over You searched for: Author "Hovius, Joppe W." Remove constraint Author: "Hovius, Joppe W."
430 results on '"Hovius, Joppe W."'

Search Results

1. Autochthonous Human Babesiosis Caused by Babesia venatorum, the Netherlands

2. A comprehensive genetic map of cytokine responses in Lyme borreliosis

5. Exposure, infection and disease with the tick-borne pathogen Borrelia miyamotoi in the Netherlands and Sweden, 2007-2019

6. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

7. Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19

9. Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress, and energy metabolism failure compatible with cell death

14. Development of a sequence-based in silico OspA typing method for Borrelia burgdorferi sensu lato

15. Tick-borne diseases in the North Sea region–A comprehensive overview and recommendations for diagnostics and treatment

18. Tick-borne diseases in the North Sea region–A comprehensive overview and recommendations for diagnostics and treatment

19. Persistent Symptoms After Lyme Disease: Clinical Characteristics, Predictors, and Classification.

24. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

25. Two Cases of Borrelia miyamotoi Meningitis, Sweden, 2018

31. Correction to “Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study”

32. Contributors

35. Counterattacking the tick bite: towards a rational design of anti-tick vaccines targeting pathogen transmission

38. Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi

40. Identification of novel conserved Ixodes vaccine candidates; a promising role for non-secreted salivary gland proteins

41. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

42. Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

47. Borrelia miyamotoi Disease in an Immunocompetent Patient, Western Europe

48. Identifying platelet-derived factors as amplifiers of B. burgdorferi-induced cytokine production

50. Identifying platelet-derived factors as amplifiers ofB. burgdorferi-induced cytokine production

Catalog

Books, media, physical & digital resources